Back to results
US 2023/0416788 A1Published application
Gene editing
AssigneeAdam Brian Robertson
InventorsAdam Brian Robertson, Julia Robertson, Anika Reifschneider, Arne Klungland
Life of this patent
Estimating the term…
Abstract
The present invention generally relates to systems, methods and compositions used for the control of gene expression involving sequence targeting, such as genome perturbation or gene-editing, that may use vector systems related to recombinases and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and components thereof.
Claims21
An engineered, non-naturally occurring system for altering expression of a gene product and/or genome editing comprising:
- one or more nucleic acid sequences comprising a) a nucleic acid molecule encoding an enzyme that introduces a double stranded break in a specific targeted sequence in a gene encoding said gene product in said genome of said cell, b) a nucleic acid molecule comprising a nucleic acid sequence of interest to be inserted into said genome at said double stranded break, said nucleic acid molecule comprising one or more free ends;
- and c) a nucleic acid sequence encoding a UvsX recombinase;
- wherein components (a), (b) and (c) are introduced into a eukaryotic cell so that a targeted double stranded break is introduced into the genome of said cell and said nucleic acid molecule encoding a nucleic acid sequence of interest is inserted by homologous recombination at said double stranded break to effect altered expression of at said at least one gene product and/or genome editing of said gene encoding said gene product of interest and wherein said enzyme that introduces a double stranded break in a specific targeted sequence in a gene encoding said gene product and said nucleic acid molecule encoding a nucleic acid sequence of interest to be inserted into said genome at said double stranded break do not naturally occur together.
An engineered, non-naturally occurring CRISPR-Cas system comprising:
- one or more vectors comprising:
- a) a first regulatory element operable in a eukaryotic cell operably linked to at least one nucleotide sequence encoding a CRISPR-Cas system guide RNA that hybridizes with a target sequence of a DNA molecule in a eukaryotic cell that contains the DNA molecule, wherein the DNA molecule encodes and the eukaryotic cell expresses at least one gene product,
- b) a second regulatory element operable in said cell operably linked to a nucleotide sequence encoding a Cas9 protein, and
- c) a third regulatory element operable in said cell operably linked to a nucleotide sequence encoding a UvsX recombinase,
- wherein components (a), (b) and (c) are located on same or different vectors of the system, whereby the guide RNA targets and hybridizes with the target sequence and the Cas9 protein cleaves the DNA molecule, whereby expression of the at least one gene product is altered;
- and, wherein the Cas9 protein and the guide RNA do not naturally occur together.
3 more elements
Dependencies are inferred from the claim text.